SMARCA4 and cancer: First, we aimed to assess the potential role of germline PVs in SMARCA4 along with an extended panel of 24 additional (candidate) cancer predisposition genes in a clinical cohort of 206 OC patients (including three SCCOHT index patients) with an AAD ≤40 years.